Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.50
Bid: 51.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.882%)
Open: 52.50
High: 52.50
Low: 52.50
Prev. Close: 52.50
BVT Live PriceLast checked at -
Baronsmead Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

17 Sep 2020 09:00

RNS Number : 2231Z
Baronsmead Venture Trust PLC
17 September 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

Baronsmead Venture Trust plc

17 September 2020

Publication of a Prospectus and Offer for Subscription

Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc have published a prospectus in relation to offers for subscription to raise up to £40 million in aggregate with an over-allotment facility to raise up to a further £35 million in aggregate (the "Offers").

The Offers are now open and are expected to close no later than 24 March 2021 (unless fully subscribed by an earlier date). All subscriptions will be processed on a "first come, first served" basis. Investors can subscribe for new shares online by logging on to https://www.baronsmeadvctoffer.co.uk and completing an electronic subscription form or by completing a paper subscription form which can be found at the back of the prospectus or downloaded from the Baronsmead website at http://www.baronsmeadvcts.co.uk.

Subscriptions made on or before 30 October 2020 will be entitled to an earlybird rebate on the following basis:

§ existing shareholders will receive a rebate of 0.75 per cent. of their subscription: and

§ new investors will receive a rebate of 0.5 per cent. of their subscription.

The rebate will be paid to investors in the form of additional new shares issued at the relevant Offer price. The rebate will be limited to subscriptions which represent the first £7.5 million received by each of the companies under the Offers.

As part of the Offer the Company will enter into an offer agreement, under which the Company will pay the Company's Investment Manager, Gresham House Asset Management Limited, in consideration for administering the Offer, a fee of 4.5 per cent of the gross proceeds of the Offer.

Out of this fee the Investment Manager shall pay all the costs and expenses of and incidental to the Offer and the preparation of the prospectus. The Investment Manager is a related party. As such, this transaction is a smaller related party transaction as defined in LR11.1.10R.

The prospectus will shortly be available for inspection at the National Storage Mechanism which is located at https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

The prospectus, together with the paper subscription form, is also available on the Baronsmead website at http://www.baronsmeadvcts.co.uk and on request by emailing baronsmeadvcts@greshamhouse.com.

For IFA enquiries please contact RAM Capital Partners LLP on 020 3006 7530 or email taxsolutions@ramcapital.co.uk for document requests.

For further information please contact:

Baronsmead VCT Investor Relations

020 3875 9862 baronsmeadvcts@greshamhouse.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIEQLFFBKLZBBE
Date   Source Headline
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 202411:00 amRNSShare Allotment,Total Voting Rights,Close of Offer
19th Mar 20245:37 pmRNSClose of Offer to New Applications
18th Mar 20244:46 pmRNSDirector/PDMR Shareholding
15th Mar 20244:04 pmRNSTransaction in Own Shares
6th Mar 20243:00 pmRNSNet Asset Value(s)
6th Mar 20241:22 pmRNSResult of AGM
1st Mar 202410:20 amRNSTotal Voting Rights
15th Feb 20242:05 pmRNSDirector/PDMR Shareholding
15th Feb 20242:00 pmRNSAllotment of Shares and Total Voting Rights
7th Feb 202410:00 amRNSNet Asset Value(s)
2nd Feb 20248:00 amRNSIntention to Utilise Over-allotment Facility
1st Feb 20245:18 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
30th Jan 202412:01 pmRNSDirector/PDMR Shareholding
30th Jan 202412:00 pmRNSDirector/PDMR Shareholding
26th Jan 20242:30 pmRNSAllotment of Shares and Total Voting Rights
24th Jan 20245:00 pmRNSNet Asset Value(s)
24th Jan 20244:00 pmRNSNet Asset Value(s)
22nd Jan 20243:00 pmRNSOffer Update Extension of Early Bird Discount Date
19th Jan 20242:35 pmRNSIssue of Supplementary Prospectus
5th Jan 202411:36 amRNSChange of allotment date - correction
4th Jan 20243:45 pmRNSChange of allotment date
2nd Jan 202411:00 amRNSTotal Voting Rights
22nd Dec 20237:00 amRNSAnnual Financial Report
12th Dec 20235:40 pmRNSTransaction in Own Shares
6th Dec 20231:30 pmRNSNet Asset Value(s)
24th Nov 20231:27 pmRNSPublication of a Prospectus/Offer for Subscription
22nd Nov 20237:00 amRNSCompliance with Market Abuse Regulation ("MAR")
14th Nov 202310:01 amRNSUpdate on Offer for Subscription
6th Nov 20234:01 pmRNSNet Asset Value(s)
27th Oct 20231:30 pmRNSNet Asset Value(s)
19th Oct 20234:51 pmRNSDirectorate Change
12th Oct 202311:22 amRNSAppointment of Non-Executive Director
2nd Oct 20234:00 pmRNSTotal Voting Rights
28th Sep 20235:52 pmRNSTransaction in Own Shares
12th Sep 20236:28 pmRNSTransaction in Own Shares - Replacement
12th Sep 20235:20 pmRNSTransaction in Own Shares
5th Sep 202311:00 amRNSIntention to Fundraise
4th Aug 20234:00 pmRNSNet Asset Value(s)
1st Aug 20231:52 pmRNSTotal Voting Rights
27th Jul 20234:11 pmRNSTransaction in Own Shares
24th Jul 20232:00 pmRNSNet Asset Value(s)
3rd Jul 202311:26 amRNSTotal Voting Rights
20th Jun 20233:45 pmRNSTransaction in Own Shares
13th Jun 20237:00 amRNSHalf-yearly Report
6th Jun 20235:30 pmRNSNet Asset Value(s)
12th May 20237:00 amRNSCompliance with the Market Abuse Regulation
5th May 20235:30 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.